Viewpoint
- Within our broader approach to ESG, specific attention is directed towards governance, namely board composition, executive pay and incentives. We believe this is of particular importance when assessing smaller, growing companies.
- A unique feature of investing in small caps is the prevalence of founder-led businesses. Founders, through extended tenure, large shareholdings and cultural influence can challenge governance objectives, including board independence.
- Growing, maturing companies need to ensure that executive incentive structures are transparent and appropriately tailored – and ultimately anchor to shareholder returns.
As the significance of environmental, social, and governance (ESG) factors continues to rise in the investment landscape, and discussions centre around decarbonisation, emissions, and climate change, the critical role of governance can sometimes be overshadowed.
In the context of the Australian small-cap sector, we believe governance is currently the most influential ESG factor driving shareholder returns, as shown by the extensive back-testing conducted by our team. This belief shapes our research efforts and company engagement strategies for the Maple-Brown Abbott Australian Small Companies Fund.
Board composition and the role of founders
Board composition, being pivotal to both governance and shareholder returns, demands a nuanced evaluation of diversity, skills, independence and alignment with shareholders.
In our observations, the heavy influence of founders within smaller, newer companies is a prevailing feature of the small cap cohort. Implicit in the name, these key individuals commonly retain senior executive roles and substantial shareholdings back to a company’s genesis. Balancing a founder’s undeniable influence against the need for independent thought can become a delicate task, contingent on company performance and board effectiveness.
We also recognise that a director’s extended tenure has the potential (inadvertent or otherwise) to compromise board independence, as directors who have been with a company from its inception may develop particularly close relationships with employees, suppliers and customers, potentially biasing their oversight role. Consequently, maintaining objectivity where directors have been on a board beyond 10-12 years becomes a critical consideration.
Where the board has discretion to determine whether performance objectives were met in compensation plans this independence and objectivity is even more important. Further to this we also stress the importance of separating the roles of the chairperson and CEO for effective oversight.
Executive incentives
The realm of executive pay and incentives is a crucial consideration for investors, as it is central to determining management priorities. We believe aligning incentives with activities that enhance shareholder returns becomes paramount for smaller companies, particularly those operating in rapidly evolving markets. We look for tailored incentive schemes respecting all stakeholders, for example safety metrics in short-term incentives may be pertinent for the mining sector, whereas new customer contracts may drive positive returns for technology companies.
In cases where we observe poor incentive alignment, particularly in management receiving additional compensation for routine activities, we engage with the company and exercise our voting rights by opposing remuneration reports and other incentive packages during annual general meetings. The outcome of exercising these voting rights will largely depend on the number of voting shares we may hold in a company, and the extent to which other shareholders are like-minded in their view.
Transparency is key
The best incentive programs are transparent, measurable and easily comprehensible. High expectations for detailed, metricated disclosure and industry-specific tailoring underscore our commitment to transparency. During recent engagements in proxy voting seasons, as active and engaged investors we agitated for increased disclosure of short-term incentive performance indicators on a number of occasions. This also extended to pushing for greater transparency of long-term incentives, advocating for clear, objective measures such as relative shareholder return and earnings per share growth.
We scrutinise whether management targets are sufficiently challenging to warrant performance incentives, firmly believing that financial metrics should align with driving shareholder returns, echoing our philosophy that earnings drive share prices we believe earnings per share metrics are the optimal measure of long term performance.
Incentive case study: MVF
Monash IVF Group (MVF) operate what we believe is an example of a clear and easily comprehensible incentive program. The program’s strategic objectives of patient engagement, people engagement, doctor engagement, scientific success rates, domestic market growth and doctor acquisition/retention closely align with the key business growth drivers and shareholder return. Furthermore, for each strategic objective there are clear measures of success such as net promoter scores and employee engagement percentages. In line with best practice the company discloses the annual outcome on these measures so shareholders can easily assess if incentives have been earned. While the company has an allocation to non-financial objectives, 70% of short term incentives are financial in nature, allocated to earnings per share – which is our preferred measure of financial performance in line with our investment philosophy.
Parting thought
For smaller companies, board composition and appropriate remuneration structures are central to both governance and shareholder returns. As such they demand a nuanced evaluation of, inherent biases, independence and alignment with shareholders.
In our role as active owners, we consider it our responsibility to foster good corporate governance, ultimately aimed at enhancing returns for our clients. We aim to cultivate enduring relationships with the companies in our portfolio, intending to support them throughout their growth journey while concurrently building value for our clients.
Disclaimer
This information was prepared and issued by Maple-Brown Abbott Ltd ABN 73 001 208 564, Australian Financial Service Licence No. 237296 (“MBA”). This information must not be reproduced or transmitted in any form without the prior written consent of MBA. This information does not constitute investment advice or an investment recommendation of any kind and should not be relied upon as such. This information is general information only and it does not have regard to any person’s investment objectives, financial situation or needs. Before making any investment decision, you should seek independent investment, legal, tax, accounting or other professional advice as appropriate, and obtain the relevant Product Disclosure Statement and Target Market Determination for any financial product you are considering. This information does not constitute an offer or solicitation by anyone in any jurisdiction. This information is not an advertisement and is not directed at any person in any jurisdiction where the publication or availability of the information is prohibited or restricted by law. Past performance is not a reliable indicator of future performance. Any comments about investments are not a recommendation to buy, sell or hold. Any views expressed on individual stocks or other investments, or any forecasts or estimates, are point in time views and may be based on certain assumptions and qualifications not set out in part or in full in this information. The views and opinions contained herein are those of the authors as at the date of publication and are subject to change due to market and other conditions. Such views and opinions may not necessarily represent those expressed or reflected in other MBA communications, strategies or funds. Information derived from sources is believed to be accurate, however such information has not been independently verified and may be subject to assumptions and qualifications compiled by the relevant source and this information does not purport to provide a complete description of all or any such assumptions and qualifications. To the extent permitted by law, neither MBA, nor any of its related parties, directors or employees, make any representation or warranty as to the accuracy, completeness, reasonableness or reliability of the information contained herein, or accept liability or responsibility for any losses, whether direct, indirect or consequential, relating to, or arising from, the use or reliance on any part of this information. Neither MBA, nor any of its related parties, directors or employees, make any representation or give any guarantee as to the return of capital, performance, any specific rate of return, or the taxation consequences of, any investment. This information is current at 11 December 2023 and is subject to change at any time without notice. You can access MBA’s Financial Services Guide here for further information about any financial services or products which MBA may provide. © 2023 Maple-Brown Abbott Limited.
Ayesha joined Maple-Brown Abbott in October 2022 as an ESG Investment Analyst. In her current role, she is responsible for conducting environmental, social and governance (ESG) stock research and analysis for Australian small cap companies as well as supporting broader ESG efforts. Before joining Maple-Brown Abbott, Ayesha worked as an assistant investment analyst in the global equities team at Pendal Group, covering the consumer staples and chemicals sectors across North America, Europe and Japan.
Ayesha
Interested in investing with us?
Investment Insights
Of Burritos and (inedible) Chips
The tale of two research trips: AI fizz in the US meets gloom across the ditch
A good recent run for the Big Four banks, but where to next?
